These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12527469)

  • 1. The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity.
    Henry SA; Lehmann-Masten V; Gasparini F; Geyer MA; Markou A
    Neuropharmacology; 2002 Dec; 43(8):1199-209. PubMed ID: 12527469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents.
    Kinney GG; Burno M; Campbell UC; Hernandez LM; Rodriguez D; Bristow LJ; Conn PJ
    J Pharmacol Exp Ther; 2003 Jul; 306(1):116-23. PubMed ID: 12660307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of effect of LY314582 (a group 2 metabotropic glutamate receptor agonist) on phencyclidine-induced locomotor activity in metabotropic glutamate receptor 2 knockout mice.
    Spooren WP; Gasparini F; van der Putten H; Koller M; Nakanishi S; Kuhn R
    Eur J Pharmacol; 2000 May; 397(1):R1-2. PubMed ID: 10844118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats.
    Campbell UC; Lalwani K; Hernandez L; Kinney GG; Conn PJ; Bristow LJ
    Psychopharmacology (Berl); 2004 Sep; 175(3):310-8. PubMed ID: 15024550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite influence of MPEP, an mGluR5 antagonist, on the locomotor hyperactivity induced by PCP and amphetamine.
    Pietraszek M; Rogóz Z; Wolfarth S; Ossowska K
    J Physiol Pharmacol; 2004 Sep; 55(3):587-93. PubMed ID: 15381829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mGluR5, but not mGluR1, antagonist modifies MK-801-induced locomotor activity and deficit of prepulse inhibition.
    Pietraszek M; Gravius A; Schäfer D; Weil T; Trifanova D; Danysz W
    Neuropharmacology; 2005 Jul; 49(1):73-85. PubMed ID: 15992582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prepulse inhibition of the startle reflex in rats: effects of compounds acting at various sites on the NMDA receptor complex.
    Depoortere R; Perrault G; Sanger DJ
    Behav Pharmacol; 1999 Feb; 10(1):51-62. PubMed ID: 10780302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties.
    Swedberg MD; Ellgren M; Raboisson P
    J Pharmacol Exp Ther; 2014 Apr; 349(1):155-64. PubMed ID: 24472725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat.
    Klamer D; Zhang J; Engel JA; Svensson L
    Behav Brain Res; 2005 Apr; 159(1):95-103. PubMed ID: 15795002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
    Lea PM; Movsesyan VA; Faden AI
    Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LY354740 affects startle responding but not sensorimotor gating or discriminative effects of phencyclidine.
    Schreiber R; Lowe D; Voerste A; De Vry J
    Eur J Pharmacol; 2000 Jan; 388(2):R3-4. PubMed ID: 10666513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats.
    Kenny PJ; Gasparini F; Markou A
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1068-76. PubMed ID: 12805481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats.
    Koltunowska D; Gibula-Bruzda E; Kotlinska JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():242-9. PubMed ID: 23623810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
    Cartmell J; Monn JA; Schoepp DD
    J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a metabotropic glutamate receptor group II agonist LY354740 in animal models of positive schizophrenia symptoms and cognition.
    Schlumberger C; Schäfer D; Barberi C; Morè L; Nagel J; Pietraszek M; Schmidt WJ; Danysz W
    Behav Pharmacol; 2009 Feb; 20(1):56-66. PubMed ID: 19179851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism.
    O'Leary DM; Movsesyan V; Vicini S; Faden AI
    Br J Pharmacol; 2000 Dec; 131(7):1429-37. PubMed ID: 11090117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
    Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
    Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents.
    Spooren WP; Vassout A; Neijt HC; Kuhn R; Gasparini F; Roux S; Porsolt RD; Gentsch C
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1267-75. PubMed ID: 11082464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit.
    Chaperon F; Müller W; Auberson YP; Tricklebank MD; Neijt HC
    Behav Pharmacol; 2003 Sep; 14(5-6):477-87. PubMed ID: 14501261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive and negative modulation of circadian activity rhythms by mGluR5 and mGluR2/3 metabotropic glutamate receptors.
    Gannon RL; Millan MJ
    Neuropharmacology; 2011; 60(2-3):209-15. PubMed ID: 20831878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.